New cancer cases are projected to surpass 2 million in 2024 - a first in for the U.S., according to American Cancer Society’s Cancer Facts & Figures 2024 report.
The landmark projection amounts to 5,500 diagnoses a day.
The American Cancer Society attributes the rise in cases to a growing and aging population along with an increase in diagnoses of six common cancers – breast, prostate, endometrial, pancreatic, kidney, and melanoma.
In addition, the organization is projecting over 611,000 deaths from cancer in 2024, a .19% increase from 2023. That is more than 1,600 deaths each day!
While cancer is prevalent across people of all races, ethnicities, ages, genders, and backgrounds, it disproportionately continues to affect people of color, such as Latinos.
Cancer in ...
Do you get the recommended 7-10 hours of sleep a night? Insufficient sleep and poor sleep quality contribute to the development and management of many health issues, from diabetes to heart disease, according to the CDC. Researchers at UT Health San Antonio and their partners are studying sleep disturbances among blood cancer patients and comparing effectiveness of two wellness-based mobile apps to help improve sleep. The Reducing Sleep disTurbance in Cancer (REST-C) study, also called the Heme Study, is a clinical trial that is currently recruiting adults diagnosed with blood cancer and experiencing sleep disturbance. A clinical trial is a study that helps researchers learn more about how different treatments and interventions can be used to help slow, manage, and ...
The COVID-19 pandemic hurt public trust in healthcare and science. Trust is especially low among communities that experience health disparities and barriers to healthcare, according to Dr. David W. Baker of The Joint Commission in Illinois. “Black and Latino communities faced inadequate testing, financial barriers to care, and disproportionately high rates of COVID-19 cases and deaths, further threatening their trust in physicians, the health care system, public health, and science,” Baker wrote in his article, Trust in Health Care in the Time of COVID-19. Misinformation and a lack of trust in healthcare can spur a cycle of reduced care and ultimately contribute to worse health outcomes. But how can trust in healthcare be restored?
Reasons for Latino Distrust in ...
Clinical trials have led to the development of better treatments, life-saving medicines, and new prevention strategies for cancer and other diseases. Still, clinical trials have lacked volunteers who are Latino. We need diverse representation in clinical trials to ensure health and medical discoveries are equitable for diverse populations. To promote clinical trials, let’s use #SaludTues on Tuesday, Dec. 5, 2023, to discuss reasons why Latinos and all people should consider joining a clinical trial! WHAT: #SaludTues Tweetchat: Why Should You Try a Clinical Trial?
TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, Dec. 5, 2023
WHERE: On Twitter with hashtag #SaludTues
HOST: @SaludAmerica
CO-HOSTS: Latinx Voces LLC (@latinxvocesllc); LatinaStrong Foundation ...
News of a cancer diagnosis is the last thing anyone wants to hear. It can be especially devastating for a teenager with no family history of cancer. That was reality for Amber Lopez. Lopez, a San Antonio resident who began experiencing symptoms around age 14, was eventually diagnosed with cervical cancer a few years later at 18. “When you hear that word cancer, you’re kind of like, 'Oh, my God. OK. So, does that mean like, I’m going to pass away? How does this work?'” Lopez said. Since her diagnosis, Lopez has overcome many challenges in her cancer journey. Now she’s sharing her story through the Avanzando Caminos study at UT Health San Antonio to give hope to other Latino cancer survivors.
Navigating Her Cancer Diagnosis
Latinas ...
Dr. Amelie G. Ramirez, leader of Salud America! at UT Health San Antonio, joined The Washington Post's live show to share how cancer screening can help patients get diagnosed and treated earlier The show, "Chasing Cancer: The Path Forward," sponsored by AstraZeneca, took place Nov. 8, 2023. In the first part of of the show, Renee Wegrzyn, director of the Advanced Research Projects Agency for Health (ARPA-H), and Eric Topol, executive vice president of Scripps Research, discussed how technological advancements and AI are changing how cancer is diagnosed and treated. In the second part of the show, Ramirez teamed with Dr. Gladys I. Rodriguez, a medical oncologist with the START Center for Cancer Care, to discuss innovative initiatives make it easier to access early screenings, ...
Researchers need your help as they seek to better understand how lung cancer impacts people differently and how to improve treatment and quality of life. That’s why the GO2 Foundation for Lung Cancer started its Lung Cancer Registry. The international Lung Cancer Registry, available to join now, aims to double the 5-year survival rate of lung cancer patients from 20% to 40% by 2025. “By sharing your lung cancer story, contributing your experiences as a person with lung cancer or a caregiver of someone with lung cancer, you are helping the research community develop new treatments,” according to GO2. Let’s dive into more about the registry, how you can join, and how it can help Latinos.
Joining the Lung Cancer Registry
Participants interested in ...
“It was kind of a fluke.” That’s how Angelina Vazquez Felsing describes the events that led to her diagnosis of lung cancer. Like many, Vazquez Felsing maintained a healthy lifestyle. She didn’t smoke. She ate healthy, ran regularly, and had no family history of cancer. Vazquez Felsing, who immigrated from Mazatlán, Mexico, in 1972, grew up in the Floresville area and has lived in San Antonio for many years. It all started when Vazquez Felsing went to her yearly checkup through the wellness program at her job, where she has worked as a systems analyst for 17 years. “They found something that was a little bit odd. They said, ‘Well come back in a year, and we'll do another CT scan,’” she said. “And when I went back, they found that whatever ...
Colorectal cancer is a leading cause of cancer death among people of Hispanic and Latino descent in the United States. Adan Reinosa Rivera, a retired electrical engineer in Los Angeles, is doing his part to change that. Mr. Reinosa has been living with metastatic colorectal cancer for more than a decade. The cancer was detected in his lungs a few months after a tumor was removed from his colon. He’s been managing the disease with his doctor ever since. Now, as the first participant in a genetic study called ENLACEExit Disclaimer, Mr. Reinosa is helping to build a body of knowledge about the molecular features of colorectal cancers in Hispanic and Latino people. The study, supported by the Cancer MoonshotSM, aims to learn more about the disease in people of Hispanic and ...
